About
Dr. Deepali Pal is a researcher at Newcastle University, where she leads cutting-edge studies in leukemia biology and stem cell research. Her work focuses on understanding the bone marrow microenvironment's role in treatment resistance and developing innovative 3D models for cancer drug testing.
Research Interests: Dr. Pal's investigations span multiple disciplines including:
- Leukemia microenvironment interactions
- Stem cell-derived cancer models
- Epigenetic drivers of treatment resistance
- Non-animal testing platforms for drug development
- Therapeutic targeting of redox systems
- Chromosomal instability mechanisms in blood cancers
Her recent publications demonstrate a strong emphasis on translational oncology, with frequent use of patient-derived models, organoid engineering, and molecular profiling to identify clinically actionable targets. The work consistently bridges basic cancer biology with therapeutic innovation.
0Publications listed
